Preventive Vaccines Market Is Estimated to Witness High Growth Owing to Growing Adoption for Preventing Infectious Diseases
Preventive Vaccines
Market
Market
Overview:
Preventive vaccines are biologic products that help develop immunity against a
future infection with a particular disease. They contain agents that resemble
disease-causing microorganisms and are administered through needle injections
or orally. Preventive vaccines are given to protect public from infectious
diseases such as poliomyelitis, hepatitis, influenza, pneumonia and many more.
They help strengthen the immune system so it can fight the real infection if
exposed in the future.
Market Dynamics:
The preventive vaccines market is witnessing high growth owing to growing
adoption of vaccines for preventing infectious diseases and rising awareness
about vaccination programs. Moreover, increasing research and development
activities by key players for development of new preventive vaccines along with
government support through vaccination programs in developing countries is
further propelling the market growth. However, rising concerns regarding
side-effects of vaccination and low availability of preventive vaccines in
remote areas is challenging the market growth.
SWOT Analysis
Strength:
Preventive Vaccines have proven to be highly effective in eradicating several
infectious diseases. They help build immunity against future infections in a
cost effective manner. The development of new preventive vaccines to fight
emerging diseases is a major strength.
Weakness: Distribution and storage of some preventive vaccines requires a
temperature controlled cold chain which can be challenging in remote areas with
lack of infrastructure. The need for regular booster doses is another weakness
as it affects compliance.
Opportunity: The rising awareness about preventive healthcare and savings on
treatment costs provides an opportunity to increase vaccination rates
worldwide. The high growth markets in developing countries present a lucrative
opportunity.
Threats: Vaccine hesitancy due to safety concerns can negatively impact market
growth. Strict regulations around clinical trials also delay market entry of
new vaccines.
Key Takeaways
The Global
Preventive Vaccines Market Demand is expected to witness high growth,
exhibiting CAGR of 9.4% over the forecast period, due to increasing government
focus on immunization programs globally. Major regulatory bodies such as the
WHO and governments of various countries extensively support vaccination drives
with favorable policies and funding.
Regional analysis: North America dominated the preventive vaccines market in
2023 with a share of over 30%, due to high adoption and availability of novel
and routine vaccination offerings. However, Asia Pacific is expected to exhibit
the fastest growth, with a CAGR of around 11% during the forecast period. Rising
healthcare infrastructure and disposable incomes in developing Asian countries
drive the growth of preventive vaccines market in the region.
Key players: Key players operating in the preventive vaccines market are Sanofi
SA, Pfizer Inc., Novavax Inc., Merck & Co. Inc., Johnson & Johnson,
GlaxoSmithKline PLC, Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc.,
AstraZeneca, and Takeda Pharmaceutical Company Limited, among others. Major
players focus on R&D to develop novel preventive vaccine candidates in high
growth therapeutic areas.
Read
More:
https://www.marketwebjournal.com/preventive-vaccines-market-growth-demand-and-overview/
Comments
Post a Comment